NYMOX PHARMACEUTICAL CORPORATION Operating Lease Income
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Operating Lease Income of -$3.00 thousand for the 3-month period ending 2022-06-30, per its 6-K filed 2022-08-15.
Discontinued › Income Statement › Other Income
ifrs-full:OperatingLeaseIncome · last filed 2022-08-15
- NYMOX PHARMACEUTICAL CORPORATION operating lease income for the quarter ending 2022-06-30 was -$3.00K.
- NYMOX PHARMACEUTICAL CORPORATION operating lease income for the quarter ending 2021-09-30 was -$9.00K.
- NYMOX PHARMACEUTICAL CORPORATION operating lease income for the quarter ending 2021-06-30 was -$4.00K.
- NYMOX PHARMACEUTICAL CORPORATION operating lease income for the quarter ending 2020-09-30 was -$11.00K.
| Period end | Operating Lease Income 3 month | Operating Lease Income 6 month | Operating Lease Income 9 month | Operating Lease Income 12 month | Operating Lease Income 12 month as first filed |
|---|---|---|---|---|---|
| 2022-06-30 | -$3.00K 6-K · filed 2022-08-15 | -$10.00K 6-K · filed 2022-08-15 | |||
| 2021-09-30 | -$9.00K 6-K · filed 2021-11-12 | -$13.00K derived: sum of 2 quarters · filed 2022-08-15 | -$30.00K 6-K · filed 2021-11-12 | ||
| 2021-06-30 | -$4.00K 6-K · filed 2022-08-15 | -$10.00K 6-K · filed 2022-08-15 | |||
| 2020-09-30 | -$11.00K 6-K · filed 2021-11-12 | -$14.00K derived: sum of 2 quarters · filed 2021-11-12 | -$31.00K 6-K · filed 2021-11-12 | ||
| 2020-06-30 | -$3.00K 6-K · filed 2021-08-13 | -$7.00K 6-K · filed 2021-08-13 | |||
| 2018-12-31 | $272.44M 20-F · filed 2019-03-29 | ||||
| 2017-12-31 | $279.64M 20-F · filed 2019-03-29 | $27.96M 20-F · filed 2018-03-30 | |||
| 2016-12-31 | $264.82M 20-F · filed 2019-03-29 |